The Valley Desk

NCT04892017 · Interventional trial

Study of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid Tumors

Overall registry status Terminated

Phase 1

Conditions Advanced Solid Tumor, Metastatic Solid Tumor, Non-Small Cell Lung Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov